Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -63.52% is 44% below its 5-year average of -44.19%, near the low end of its 5-year range (-77.49%–-18.09%).
As of the fiscal period ended Tuesday, June 30, 2026. 0.04% above its 12-month average of -63.55%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -63.52%.
RETURN ON INVESTED CAPITAL (ROIC)
-63.52%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-63.55%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-52.56%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-44.19%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
-56.33%
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
+0.04%
CURRENT VS 3Y AVG
-20.86%
CURRENT VS 5Y AVG
-43.74%
CURRENT VS 10Y AVG
-12.78%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-32.40%
median of 630 covered companies
CURRENT VS SECTOR MEDIAN
-96.06%
vs the sector median at left
Aldeyra The
Market Cap
$54.89M
Return on Invested Capital (ROIC)
-63.52%
TTM Avg
-63.55%
3Y Avg
-52.56%
5Y Avg
-44.19%
Market Cap
$55.06M
Return on Invested Capital (ROIC)
-353.68%
TTM Avg
-236.80%
3Y Avg
-128.97%
5Y Avg
-95.70%
Market Cap
$54.25M
Return on Invested Capital (ROIC)
-40.53%
TTM Avg
-31.24%
3Y Avg
-37.98%
5Y Avg
-33.19%
Market Cap
$56.78M
Return on Invested Capital (ROIC)
-68.91%
TTM Avg
-68.91%
3Y Avg
-68.91%
5Y Avg
-118.87%
Market Cap
$52.46M
Return on Invested Capital (ROIC)
-38.04%
TTM Avg
-22.77%
3Y Avg
-89.18%
5Y Avg
-83.00%
Market Cap
$52.13M
Return on Invested Capital (ROIC)
N/A
TTM Avg
-690.86%
3Y Avg
-402.79%
5Y Avg
-302.68%
Market Cap
$52.05M
Return on Invested Capital (ROIC)
13.63%
TTM Avg
32.98%
3Y Avg
9.79%
5Y Avg
24.14%
Market Cap
$57.98M
Return on Invested Capital (ROIC)
-43.97%
TTM Avg
-40.46%
3Y Avg
-48.41%
5Y Avg
-43.33%
Market Cap
$51.33M
Return on Invested Capital (ROIC)
-208.76%
TTM Avg
-1171.68%
3Y Avg
-1173.13%
5Y Avg
-939.08%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Aldeyra The (ALDX) | $54.89M | -63.52% | -63.55% | -52.56% | -44.19% |
| Spectral AI, Inc. (MDAI)vs › | $55.06M | -353.68% | -236.80% | -128.97% | -95.70% |
| ImageneBio Inc (IMA)vs › | $54.25M | -40.53% | -31.24% | -37.98% | -33.19% |
| OKYO Pharma Limited (OKYO)vs › | $56.78M | -68.91% | -68.91% | -68.91% | -118.87% |
| Dogwood Therapeutics, Inc. (DWTX)vs › | $52.46M | -38.04% | -22.77% | -89.18% | -83.00% |
| Eloxx Pharmaceuticals, Inc. (ELOX)vs › | $52.13M | N/A | -690.86% | -402.79% | -302.68% |
| biote Corp. (BTMD)vs › | $52.05M | 13.63% | 32.98% | 9.79% | 24.14% |
| Boundless Bio, Inc. (BOLD)vs › | $57.98M | -43.97% | -40.46% | -48.41% | -43.33% |
| Envoy Medical, Inc. (COCH)vs › | $51.33M | -208.76% | -1171.68% | -1173.13% | -939.08% |
| eXoZymes, Inc. (EXOZ)vs › | $51.33M | -157.40% | -135.65% | -123.35% | -111.97% |
ROIC
-63.5%
ROE
-60.9%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -63.52% |
| 2026-03-31 | -49.40% |
| 2025-12-31 | -59.27% |
| 2025-09-30 | -70.02% |
| 2025-06-30 | -75.53% |
| 2025-03-31 | -77.49% |
| 2024-12-31 | -69.87% |
| 2024-09-30 | -49.42% |
| 2024-06-30 | -37.87% |
| 2024-03-31 | -26.24% |
| 2023-12-31 | -30.30% |
| 2023-09-30 | -36.22% |
| 2023-06-30 | -38.13% |
| 2023-03-31 | -41.13% |
| 2022-12-31 | -37.57% |
| 2022-09-30 | -36.18% |
| 2022-06-30 | -34.29% |
| 2022-03-31 | -29.99% |
| 2021-12-31 | -25.40% |
| 2021-09-30 | -22.15% |
| 2021-06-30 | -18.09% |
| 2021-03-31 | -26.62% |
| 2020-12-31 | -48.82% |
| 2020-09-30 | -45.21% |
| 2020-06-30 | -71.98% |
| 2020-03-31 | -95.08% |
| 2019-12-31 | -100.74% |
| 2019-09-30 | -93.80% |
| 2019-06-30 | -78.88% |
| 2019-03-31 | -61.85% |
| 2018-12-31 | -45.83% |
| 2018-09-30 | -119.06% |
| 2018-06-30 | -77.55% |
| 2018-03-31 | -69.32% |
| 2017-12-31 | -54.93% |
| 2017-09-30 | -42.54% |
| 2017-06-30 | -80.50% |
| 2017-03-31 | -64.20% |
| 2016-12-31 | -81.40% |
| 2016-09-30 | -68.12% |
| 2016-06-30 | -54.96% |
| 2016-03-31 | -68.04% |
| 2015-12-31 | -45.82% |
| 2015-09-30 | -33.56% |
| 2015-06-30 | -26.50% |
| 2015-03-31 | -53.91% |
| 2014-12-31 | -96.46% |
| 2014-09-30 | -64.10% |
| 2014-06-30 | -47.93% |
| 2014-03-31 | -178.98% |
| 2013-12-31 | -112.04% |
| 2013-09-30 | -97.79% |
